Objectives-The purpose of our study was to highlight the conventional and contrast-enhanced ultrasound (US) features of mummified thyroid nodules, which should help differentiate them from histologically proven papillary thyroid carcinomas (PTCs).
W
ith the wide application of high-frequency ultrasound (US), the detection of thyroid nodules has gradually increased over recent years, and differentiated thyroid cancer is becoming increasingly prevalent. Various thyroid imaging reporting and data systems for US features can be used to improve the diagnostic accuracy of thyroid nodules. 1, 2 However, some typically benign thyroid nodules may spontaneously shrink, decreasing in size, while progressively showing morphologic changes that could be mistaken for malignant features on US examinations over time. 3 This process involving morphologic changes, known as thyroid nodule mummification, may occur spontaneously over time or may result from thyroid nodule fine-needle aspiration (FNA) or percutaneous ethanol or laser ablation. [4] [5] [6] [7] Therefore, it is important to differentiate mummified thyroid nodules from thyroid carcinomas in avoid unnecessary thyroid surgery.
Contrast-enhanced ultrasound (CEUS), as one of the novel US modalities, could provide much better characterization of dynamic microvessel perfusion in the differential diagnosis of focal thyroid nodules than conventional US. 8, 9 However, to our knowledge, no studies have reported the CEUS features of mummified thyroid nodules and their differences from papillary thyroid carcinomas (PTCs). The purpose of our study was to highlight the grayscale, color Doppler, and contrastenhanced US features of mummified thyroid nodules, which should help differentiate them from histologically proven PTCs.
Materials and Methods

Patients
The study was approved by the Ethical Committee of the Second Xiangya Hospital of Central South University and was performed in accordance with the Declaration of Helsinki for human studies. From July 2016 to January 2017, 42 patients with 45 thyroid nodules who received conventional US and CEUS examinations were recruited for this study. The inclusion criteria were as follows: (1) patients with thyroid nodules that were confirmed as benign by pathologic examinations after surgery or by fine-needle aspiration biopsy (FNAB); (2) nodules that were suspected to be malignant according to conventional US; (3) initial US findings of partially cystic nodules with no suspicious features; and (4) no invasive procedures, such as thyroid surgery and FNA, had been previously performed. Among them, 11 patients with no follow-up US examinations or further FNAs were excluded. Finally, 31 patients with 33 thyroid nodules were included in this study.
In addition, from July 2016 to January 2017, 46 patients with 54 thyroid nodules who received conventional US and CEUS examinations were recruited for this study as a control group. The inclusion criteria were as follows: (1) patients with thyroid nodules that were confirmed to be PTCs by pathologic examination after surgery; (2) nodules that were suspected to be malignant on conventional US imaging; and (3) no invasive procedure, such as thyroid surgery or FNA, had been previously performed. According to a study by Moon et al, 10 the diagnostic accuracy of conventional US for malignant thyroid nodules depends on the tumor size. In line with the study group, all nodule sizes in the control group were less than 20 mm. A total of 13 patients with 16 thyroid nodules were excluded due to nodule sizes that were more than 20 mm. Finally, 33 patients with 38 thyroid nodules were included in this study. Ultimately, a total of 71 thyroid nodules in 64 patients were included in this study (Figure 1 ).
Conventional US and CEUS
An Acuson S3000 US scanner (Siemens Medical Solutions, Mountain View, CA) and CEUS imaging Figure 1 . Flowchart for the selection of thyroid nodules. AUS/FLUS indicates atypia or follicular lesion of undetermined significance; FN/SFN, follicular neoplasm or suspicious for a follicular neoplasm; and SUSP, suspicious for malignancy technology were used in this study. A 9 L4 linear array transducer (4-9 MHz) was equipped for conventional US and CEUS examinations, and an 18 L6 linear array transducer (6-18 MHz) was used for conventional US. Sulfur hexafluoride microbubbles (SonoVue, Bracco SpA, Milan, Italy) were used as the US contrast agent in this study. To exclude the variability among different operators and to ensure optimized image quality, all examinations were performed by the same operator, who had 20 years of experience in thyroid US diagnosis and 3 years of experience in performing CEUS examinations, and the conventional US examinations were performed before the CEUS examinations. All selected thyroid nodules were evaluated by conventional B-mode and color Doppler US for size, shape, margin, echogenicity, posterior shadowing, halo, punctate echogenic foci, and vascularity.
After each conventional US examination, the CEUS examination was performed by using contrast pulse sequencing technology with a low mechanical index (0.07). Using a 20-gauge antecubital vein cannula, SonoVue was injected intravenously as a bolus of 3.0 mL, followed by a saline flush of 5 mL. Simultaneously, the timer on the S3000 US scanner was started, and the imaging lasted at least 60 seconds. The CEUS videos were digitally recorded for further analysis.
Image Interpretation and Analysis
Two other investigators, with 5 years of experience in thyroid US diagnosis and 2 years of experience in performing CEUS, analyzed the US images independently. Different opinions were solved via consensus.
The conventional US features of the thyroid nodules were evaluated in terms of size (the largest diameter), shape (taller than wide or wider than tall), margin (well defined or poorly defined), echogenicity (markedly hypoechoic, hypoechoic, isoechoic, or hyperechoic), posterior shadowing (present or absent), double black-andwhite halo signs (double hypoechoic and hyperechoic rim; present or absent), punctate echogenic foci (present or absent), and vascularity (no peripheral or internal blood flow or peripheral and/or internal blood flow). The nodules were classified according to the Thyroid Imaging Reporting and Data System (TI-RADS) proposed by Kwak et al. 1 According to that classification 5 US suspicious features (solid component, hypoechogenicity or marked hypoechogenicity, microlobulated or irregular margins, taller-than-wide shape, and presence of microcalcifications) were applied to categorize the thyroid nodules: TI-RADS score 3 (no suspicious US features), 4a (1 suspicious US feature), 4b (2 suspicious US features), 4c (3 or 4 suspicious US features), and 5 (5 suspicious US features).
The CEUS analysis was performed with dedicated software (Contrast Dynamics, Mountain View, CA), and the time-intensity curves within selected region of interest were acquired. Compared with the surrounding thyroid parenchymal tissue enhancement, the CEUS features of the thyroid nodules were classified as follows: enhancement type (hyperenhancement, isoenhancement, hypoenhancement, or no enhancement), peak intensity (expressed as a percentage; maximum intensity = 100%), time to peak (expressed in seconds), mean transit time (expressed in seconds), and area under the curve (AUC; expressed in percentage by seconds). The peak intensity, time to peak, mean transit time, and AUC values of the nodules are reported as indices by the ratio of the region of interest in the nodules to the region of interest in the thyroid parenchymal tissue.
Previous and Follow-up US
In the study group, the previous US images of suspicious thyroid nodules over time were evaluated by using a picture archiving and communication system to analyze the US changes. The mean interval between the initial finding of a thyroid nodule with no suspicious US features and the finding of suspicious US results was calculated.
After the conventional US and CEUS examinations, FNA or surgery was performed for the suspicious nodules. Each patient was required to receive US as a follow-up after FNA for a minimum of 6 months.
Reference Standard
For the final diagnosis of malignant thyroid nodules, only the histopathologic results after surgery were used as the reference standard, whereas for benign thyroid nodules, in addition to the histopathologic results after surgery, the results from the repeated FNA and FNA within at least 6 months of the follow-up US were used as the reference standard. According to the Bethesda system, FNA cytologic diagnoses were divided into 6 categories as follows: nondiagnostic, benign, atypia or follicular lesion of undetermined significance, follicular neoplasm or suspicious for a follicular neoplasm, suspicious for malignancy, and malignant. 11 
Statistics Analyses
The statistical analyses were performed with SPSS version 17.0 software (IBM Corporation, Armonk, NY). Continuous data (including the ages of patients and the diameters of the legions) are presented as the mean and standard deviation, as compared by independent t tests. Categorical data are presented as percentages, as analyzed by χ 2 tests. All US features that proved to be significant were analyzed to assess their independent association with mummified thyroid nodules by binary logistic regression. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the TI-RADS for discrimination between mummified benign and malignant thyroid nodules were calculated. Comparisons of the diagnostic accuracy were performed by a χ 2 test. Statistically significant differences were determined as P < .05.
Results
The study group consisted of 8 (25.8%) men and 23 (74.2%) women. The mean age of the patients ± SD was 44.8 ± 11.4 years and ranged from 13 to 61 years. The mean diameter of the lesions was 10.73 ± 2.64 mm and ranged from 7 to 16 mm. The control group consisted of 11 (33.3%) men and 22 (66.7%) women. The mean age of the patients was 39.9 ± 9.4 years and ranged from 17 to 63 years. The mean diameter of the lesions was 10.79 ± 3.82 mm and ranged from 6 to 18 mm. The results of independent t tests indicated that the ages of the patients and the diameters of the lesions had no significant difference between the groups (P > .05).
In the study group, a total of 31 patients with 33 mummified thyroid nodules were included in the analysis. Two (6.1%) nodules underwent total thyroidectomy for a PTC on the other lobe; the mummified nodules were benign by FNA cytologic examinations and were shown to be nodular goiters by paraffin section examinations. Seven (21.2%) nodules underwent partial thyroidectomy because the cytopathologic examination revealed atypia or follicular lesions of undetermined significance by US-guided FNA and the patient's request for the operation, and the nodules were benign, as confirmed by histopathologic examinations. The remaining 24 (72.7%) nodules underwent FNA: 22 were found to be benign, and 2 were considered inadequate specimens after the initial FNA and underwent repeated FNA. All of the nodules were consistent with collapsed change of benign thyroid nodules (Table 1 ). In the PTC group, FNA cytologic diagnoses for 38 nodules were as follows: 3 (7.9%) nodules were atypia or follicular lesions of undetermined significance; 2 (5.3%) nodules were follicular neoplasm or suspicious for follicular neoplasms; 5 (13.1%) nodules were suspicious for malignancy; and 28 (73.7 %) nodules were malignant. All of the nodules were confirmed by pathologic examinations after surgery.
According to the TI-RADS diagnostic classification by Kwak et al, 1 the US performances of the mummified thyroid nodules were classified (Table 1) . Eight (24.2%) nodules showed TI-RADS score 4b (2 suspicious US features; possible malignancy); 22 (66.7%) nodules showed TI-RADS score 4c (3 or 4 suspicious US features; high possibility of malignancy); and 3 (9.1%) nodules showed TI-RADS score 5 (5 suspicious US features; highly indicative of malignancy). In this study, all mummified nodules had at least 2 suspicious US features: a solid component and hypoechogenicity or marked hypoechogenicity (Figures 2-5) .
The previous US images of suspicious thyroid nodules over time were evaluated by use of the picture archiving and communication system to analyze the US changes. All of the previous nodules were partially cystic nodules with no suspicious features. The interval between the initial finding of the thyroid nodule with no suspicious US features and the presence of suspicious US findings ranged from 4 to 76 months.
The US characteristics of these suspicious thyroid nodules are summarized in Table 2 . Seven (21.2%) 5 ). Posterior shadowing was present in 11 (33.3%) nodules, and double black-and-white halo signs were present in 10 (30.3%) nodules (Figure 2) . Eleven (33.3%) nodules had punctate echogenic foci that mimicked microcalcification. In terms of vascularity, 11 (33.3%) nodules showed neither vascularity nor peripheral or internal blood flow. In the contrast mode, 32 (97.0%) nodules showed hypoenhancement or no enhancement (Figures 3 and 5 ). Time-intensity curves showed that most of the nodules underwent slow low enhancement from the periphery to the center; the time to peak of nodules and parenchymal tissue had no significant difference, and the wash-out times of nodules were earlier or equal to those of parenchymal tissue. Among them, 5 (15.2%) nodules even showed no enhancement (no microbubbles entered the nodules; Figure 5 ). The time-intensity curve showed a straight line with 0 peak intensity. Only 1 (3.0%) nodule showed isoenhancement. The time-intensity curve showed that the peak intensity and AUC of this nodule were equal to those of parenchymal tissue. The CEUS parameters revealed that only 1 (3.0%) nodule had equal peak intensity and AUC as parenchymal tissue, so 3.0% of nodule had a peak intensity index of 1 or greater and an AUC index of 1 or greater; 16 (48.5%) nodules had longer or equal times to peak as the parenchymal tissue, so 48.5% nodules had a time to peak index of 1 or greater; and 11 (33.3%) nodules had a longer or equal time to peak to as parenchymal tissue, so 33.3% had a mean transit time index of 1 or greater.
In the PTC group, 20 (52.6%) nodules had taller-than-wide shapes. Twenty-eight (73.7%) nodules had poorly defined margins. Fifteen (39.5%) nodules showed marked hypoechogenicity. Posterior shadowing was present in 5 (13.2%) nodules, and double black-and-white halo signs were present in 5 (13.2%) nodules. Ten (26.3%) nodules had punctate echogenic foci that represented microcalcification. In terms of vascularity, only 3 (7.9%) nodules showed no vascularity. In the contrast mode, 25 (65.8%) nodules showed hypoenhancement; among them, none (0%) of the nodules did not show enhancement, and 13 (34.2%) nodules showed hyperenhancement or isoenhancement. The CEUS parameters revealed that 10 (26.3%) nodules had a peak index of 1 or greater; 21 (55.3%) nodules had an AUC index of 1 or greater; 20 (52.6%) nodules had a time to peak index of 1 or greater; and 11 (28.9%) nodules had a mean transit time index of 1 or greater.
Univariate analyses indicated that the mummified thyroid nodules more frequently showed wider-than-tall shapes, marked hypoechogenicity, the presence of posterior shadowing, the absence of nodular vascularity, hypoenhancement or no enhancement, and peak indices and AUC indices of less than 1, as measured by preoperative US and CEUS, than the PTCs (all P < .05). In particular, no enhancement on CEUS is a Figure 3 . Contrast-enhanced US images of a 43-year-old man with a predominant cystic thyroid nodule mummification process proven via a paraffin section examination after surgery. A, Contrast-enhanced US image showing hypoenhancement in the whole nodule (dashed box). B, Time-intensity curves showing a slower wash-in time, lower time to peak (Tp), and lower peak intensity and AUC values than those of the peripheral thyroid parenchyma. C, Parametric color map showing that peak intensity values for the nodule were partially blue, indicating that the peak intensity of the nodule was lower than that of the peripheral thyroid parenchyma. D, Parametric color map showing that the AUC values for the nodule were mixed with green, yellow, and red, indicating that the AUC of the nodule was lower than that of the peripheral thyroid parenchyma. MTT indicates mean transit time.
characteristic feature of mummified thyroid nodules. A binary logistic regression analysis showed that marked hypoechogenicity (β = 1.255; odds ratio = 3.510; 95% confidence interval = 1.231-10.007; P = .019) and an AUC index of less than 1 (β = 2.562; odds ratio = 12.963; 95% confidence interval =1.511-111.233; P = .019) were independent characteristics related to mummified nodules for discriminating from PTC. Receiver operating characteristic curves were applied to check the diagnostic value of the combination of significant features (marked hypoechogenicity and AUC index <1) in mummified nodules or the Kwak TI-RADS. The AUC of the combination of significant features (marked hypoechogenicity and AUC index <1) was 0.729, and the AUC of TI-RADS was 0.651 in mummified nodules. The former had a better diagnostic value than the latter. Marked hypoechogenicity and an AUC index of less than 1 were used to combine with the TI-RADS to calculate the diagnostic accuracy for mummified nodules. The TI-RADS scores 4b/4c and 4c/5 were used as cutoff values for the comparison of the TI-RADS, and the TI-RADS scores 4a/4b and 4b/4c were used as cutoff values for the comparison of the improved TI-RADS (combination of marked hypoechogenicity and AUC index <1). If the nodules had marked hypoechogenicity or an AUC index of less than 1, one score was subtracted from the TI-RADS classification. If the nodules had hypoechogenicity or an AUC index of 1 or greater, one score was added to the TI-RADS classification, and score 5 remained the same. The diagnostic performance of different methods for discrimination between benign and malignant thyroid nodules is shown in Table 3 . The improved TI-RADS score 4b/4c had sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of 78.8 %, 81.8 %, 74.6 %, 72.2%, and 79.4 %, respectively, and it yielded a significant difference compared to the TI-RADS score 4c/5 with respect to diagnostic accuracy (P = .014). There were no significant differences with respect to diagnostic accuracy between the other groups (TI-RADS score 4b/4c versus TI-RADS score 4c/5, P = .172; TI-RADS score 4b/4c versus improved TI-RADS score 4a/4b, P = .859; TI-RADS score 4b/4c versus improved TI-RADS score 4b/4c, P = .201; TI-RADS score 4c/5 versus improved TI-RADS score 4a/4b, P = .122; and improved TI-RADS score 4a/4b versus improved TI-RADS score 4b/4c, P = .459).
Discussion
Currently, US is the basic imaging modality in the diagnostic protocol for thyroid nodules and is used for initial selection of focal lesions requiring further diagnostics (eg, FNAB or surgery). However, some previously proven benign thyroid nodules often gradually show suspicious US changes on follow-up US examinations. Therefore, some patients who have changes in suspicious thyroid nodules undergo FNA or even surgery, which results in the potential for overmanagement. Figure 5 . Contrast-enhanced US images of a 60-year-old woman with a partially cystic thyroid nodule mummification process shown by FNAB. A, CEUS image showing that there was completely no enhancement in the whole nodule (dashed box). B, Time-intensity curves showing that no microbubbles entered the nodule with a peak intensity of 0% and an AUC of 0%/s. C, Parametric color map showing that the peak values of the nodule were completely deep blue, indicating that the peak intensity of the nodule was markedly lower than that of the peripheral thyroid parenchyma. D, Parametric color map showing that the AUC values for the nodule were totally deep blue, indicating that the AUC of the nodule was obviously lower than that of the peripheral thyroid parenchyma. At follow-up, an FNAB analysis showed poor cellularity and hemosiderin-containing histiocytes without malignancy. MTT indicates mean transit time; and Tp, time to peak. This prospective study involved the thyroid nodule mummification process and the comparison of the US characteristics of mummified thyroid nodules and PTCs. In our study, the thyroid nodule mummification process previously mostly presented as predominantly cystic TI-RADS score 2 thyroid nodules, with no suspicious features, rather than partially cystic thyroid nodules, with eccentric solid areas; the latter are classified as low-suspicion patterns and have an estimated risk of 5% to 10% of malignancy according to the 2015 American Thyroid Association management guidelines. 11 Over time, these nodules all spontaneously shrank as the cystic portion decreased, and no invasive procedure had been previously performed, such as thyroid surgery, FNA, or percutaneous ethanol or laser ablation. With follow-up US examinations, we observed that all of the examined mummified thyroid nodules showed decreases in size over a mean time of 24.8 months (range, 4-76 months). However, almost all of the PTCs showed volume stability over time, except in rare cases that showed partial regression in micro-PTCs. 12 Therefore, the evolution of the nodule is the most firm factor in diagnosis of mummified thyroid nodules. Thus, it is necessary and important to analyze the US changes in suspicious thyroid nodules over time by use of a picture archiving and communication system. By providing an understanding of the histologic In this study, according to the Kwak TI-RADS classification, 2 suspicious US features (solid component and hypoechogenicity or marked hypoechogenicity) were shown in all mummified nodules, so their classifications were at least TI-RADS score 4b. Even more, most of mummified nodules classified as TI-RADS score 4c had 3 or 4 suspicious US features. A systematic literature review and meta-analysis analyzed 6 publications including 10,926 nodules and found that the Kwak TI-RADS had high sensitivity and low specificity for differentiation of thyroid nodules. 13 The cutoff point for benign and malignant thyroid nodules in that review was TI-RADS score 3/4a or 4a/4b, which was far below the value in our study for our different inclusion criteria. Therefore, mummified thyroid nodules are a special kind of benign nodules with malignancy-mimicking features during interval changes, which need our full awareness. In addition, understanding the history and a careful assessment of US findings are also valuable in discriminating them from PTCs.
Over time, mummified thyroid nodules may display changes on conventional US imaging with regard to shape (taller than wide), echogenicity (marked hypoechogenicity), margins (spiculated), internal content (the presence of echogenic dots), and external acoustic artifacts (posterior shadowing and double black-and-white halos). However, wider-than-tall shapes, marked hypoechogenicity, and posterior shadowing were points of differentiation from the malignancies in our study. A wider-than-tall shape is a benign US feature of thyroid nodules that is more frequently shown in mummified nodules than in PTCs (78.8% versus 47.4%; P < .05), a finding that was not consistent with those of a previous study by Koo et al. 4 The shape of nodules may depend on the degree of asymmetric fibrous healing associated with transverse shrinking 3 ; if the fibrous healing degree in the vertical direction is bigger than that in the transverse direction, it may show a taller-than-wide shape. Marked hypoechogenicity indicates that the echogenicity is less than that of the surrounding strap muscle and is more often shown in mummified thyroid nodules than in PTCs (69.7% versus 39.5%; P < .05). Marked hypoechogenicity may result from cystic component shrinkage, necrosis, or dense fibrosis. Posterior shadowing was present in 33.3% of the mummified thyroid nodules and in almost 13.2% of the PTCs (P < .05). Shadowing may be produced by the shrinkage of a cyst, which introduces an uneven interface and asymmetric peripheral fibrosis. 3 Furthermore, in our study, the characterization of nodular vascularity and dynamic microvessel perfusion seemed more important for the differentiation of mummified thyroid nodules from histologically proven PTCs than conventional US. Compared with PTCs, mummified thyroid nodules more frequently showed an absence of nodular vascularity on Doppler imaging, hypoenhancement or no enhancement, a peak index, and an AUC index of less than 1 on CEUS imaging. However, the lack of vasculature in the nodules could not definitively rule out the possibility of PTCs because the strong fibrous connective tissue hyperplasia in PTCs prevents tumor neoangiogenesis and the micro blood vessels could not be detected by Doppler US. In the subsequent contrast mode, the difference in the microvessel perfusion was even more obvious. Compared with the 65.8% of hypoenhancement in nodules among the PTCs, 97.0% of the mummified thyroid nodules showed either hypoenhancement or no enhancement; among them, 15.2% of the nodules showed no enhancement, which did not appear in the PTCs and may be a unique feature of mummified thyroid nodules. The absence of enhancement indicated that no microbubbles entered the nodules, which reflected no real blood vessels in the mummified nodules. This finding can be explained by degenerated, collapsed benign cysts with necrosis and scant cells and tissues. Corresponding to the low enhancement, the CEUS features of peak intensity and AUC were found to be lower than the surrounding thyroid parenchymal tissue. According to the result of the binary logistic regression analysis, marked hypoechogenicity and an AUC index of less than 1 were predictive of mummified nodules for discriminating them from PTCs. The combination of these features was helpful for improving the diagnostic value of mummified thyroid nodules by comparing the receiver operating characteristic curve of only the TI-RADS. Furthermore, the improved TI-RADS score 4b/4c proved to be a better diagnostic cutoff value for discrimination of mummified thyroid nodules from malignant nodules. Therefore, familiarity with US features suggesting mummified nodules and pathologic characteristics may be helpful in reducing repeated FNA or unnecessary diagnostic surgery.
This study had several limitations. First, the final diagnosis of the benign thyroid nodules was used as the reference standard for repeated FNA and FNA with at least 6 months of follow-up US; we did not perform a final histopathologic examination for benignity. Second, the patients with US characteristics that were suspected to indicate malignancy might have not undergone surgery or further examinations; thus, an unavoidable selection bias may have existed, and further studies with larger series are needed. A largescale study with a multicenter prospective design is needed to complete our data and to provide the specificity and sensitivity of the reported US findings.
In conclusion, the diagnosis of benign thyroid nodules during US examinations can be challenging because some mummified thyroid nodules can mimic malignancy spontaneously over time. The significant US characteristics of mummified thyroid nodules more frequently were wider-than-tall shapes, marked hypoechogenicity, the presence of posterior shadowing, the absence of nodular vascularity, hypoenhancement or no enhancement, and a peak index and an AUC index of less than 1 compared with PTCs. Marked hypoechogenicity and an AUC index of less than 1 were predictive of mummified nodules for discriminating them from PTCs. No enhancement on CEUS images is a characteristic finding of benign nodule shrinkage compared with PTCs. Awareness of these findings and their connection with initial and follow-up US examinations should help identify mummified thyroid nodules and avoid surgical excision or unnecessary FNA.
